A surge of 147% in a single session is an unusual occurrence in biotech — and nearly unprecedented for a company that has spent years trading discreetly under the radar. However, that is precisely ...
A post-pandemic boom made lab space the hero of commercial real estate, an antidote to the pandemic slump and a magnet for investor cash. But the life sciences sector is losing its shine fast, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results